The who has included the development of FMBA Russia in the list of candidate vaccines against COVID-19

The world health organization (who) has included in the list of candidate vaccines against COVID-19 first Russian project. We are talking about the vaccine, Saint-Petersburg Institute of vaccines and serums FMBA Russia, which is a recombinant protein based on surface epitopes of the S protein of SARS-CoV-2.

Currently Spbniivs completed the first phase of testing on animals. The proven ability of vaccines to generate specific immune response to SARS-CoV-2.

The selected platform (recombinant proteins) is already implemented in practice in global health, which significantly increases the probability of success develop an effective and safe drug against the coronavirus SARS-CoV-2, noted in Spbniivs.

A list of candidate vaccines is based on monitoring by who of the ongoing developments around the world. Who is requesting the documents (the research results), after analysis, which takes the decision on inclusion or non-inclusion of the ongoing development of the list, which is actually a confirmation of the prospects of the current work.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]